Hormone therapy remains underused in cervical cancer care as clinicians cite key barriers

Most oncologists say they would prescribe hormone therapy to cervical cancer patients who experience early menopause from ...

Women can't get estrogen patches. Here's what the FDA is doing to help.

Estrogen patches, one of the most popular menopause treatments, have been in short supply this year. Now the FDA is working ...
News-Medical.Net

Clinical barriers prevent hormone therapy access after cervical cancer treatment

Most oncologists say they would prescribe hormone therapy to cervical cancer patients who experience early menopause from ...
Healthline

Menopause Estrogen Patches Are in Short Supply. What Are the Alternatives?

The FDA's recent removal of black box warnings on hormone therapy products triggered a prescription surge and supply shortage. All five patch manufacturers are running at full capacity but still ...
Targeted Oncology

Afuresertib-Based Combination Meets Primary End Point in Phase 3 HR+ Breast Cancer Trial

Afuresertib plus fulvestrant cuts progression risk in HR+/HER2– metastatic breast cancer with PI3K/AKT/PTEN alterations, with ...